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Background: Radical hysterectomy has been developed as a standard treatment in Stage I and II cervical cancers
with and without adjuvant therapy. However, there have been several attempts to standardize the technique of
radical hysterectomy required for different tumor extension with variable success. Total mesometrial resection as
ontogenetic compartment-based oncologic surgery - developed by open surgery - can be standardized identically
for all patients with locally defined tumors. It appears to be promising for patients in terms of radicalness as well as
complication rates. Robotic surgery may additionally reduce morbidity compared to open surgery. We describe
robotically assisted total mesometrial resection (rTMMR) step by step in cervical cancer and present feasibility data
from 26 patients.
Methods: Patients (n = 26) with the diagnosis of cervical cancer were included. Patients were treated by robotic
total mesometrial resection (rTMMR) and pelvic or pelvic/periaortic robotic therapeutic lymphadenectomy (rtLNE)
for FIGO stage IA-IIB cervical cancer.
Results: No transition to open surgery was necessary. No intraoperative complications were noted. The postoperative
complication rate was 23%. Within follow-up time (mean: 18 months) we noted one distant but no locoregional
recurrence of cervical cancer. There were no deaths from cervical cancer during the observation period.
Conclusions: We conclude that rTMMR and rtLNE is a feasible and safe technique for the treatment of
compartment-defined cervical cancer.Background
The ontogenetic compartment theory states that malig-
nant tumor growth is confined to permissive compart-
ments derived from a common primordium in embryonic
development. Tumor permeation may be facilitated in the
permissive ontogenetic compartment but suppressed at
the compartment borders [1]. The existence of develop-
mental compartments was shown first in Drosophila [2]* Correspondence: rainer.kimmig@uk-essen.de
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reproduction in any medium, provided the orand reviewed by Dahmann et al. [3]. A clinical implemen-
tation was described first for total mesorectal excision
(TME) in the treatment of rectal cancer [4,5]. Höckel and
Fritsch investigated embryonic development of the female
reproductive tract with respect to embryological different
compartments [6-8] and were able to define three dif-
ferent primordial tissue complexes from cranial to caudal:
the paramesonephric-mesonephric-Müllerian tubercle com-
plex, >the deep urogenital sinus (UGS) vaginal plate
complex and the superficial UGS-genital folds and tuberclel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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theory concerning the paramesonephric-mesonephric-
Müllerian tubercle complex in cervical cancer has been
shown for cervical cancer with respect to local tumor
control following total mesometrial resection (TMMR)
without any adjuvant radiotherapy [9,10] but also with
respect to the pattern analysis of local tumor spread in
advanced and recurrent disease [11]. It has to be questioned
whether the confirmation of these findings could funda-
mentally change the classification of radical hysterectomy
and the indication for adjuvant radiotherapy [12].
With respect to regional spread data and pelvic ther-
apeutic lymphadenectomy (tLNE), they were also sys-
tematically analyzed and also assigned to ontogenetic
lymphatic compartments, which may be classified as
external iliac nodes, paravisceral nodes, common iliac
nodes and presacral nodes [13].
The original technique has been developed and de-
scribed in open surgery. At present, increasing numbers
of minimally invasive approaches to radical surgery in
cervical cancer are being reported. However, it is diffi-
cult to compare the results while lacking a systematic
description of the different techniques used. The TMMR
and tLNE may be perfectly standardized, but the tech-
nique of robotically assisted minimally invasive prepar-
ation may differ markedly to the open approach. We
recently reported on the technique of therapeutic pelvic
and paraaortic lymphadenectomy transferred to robotic
surgery in genital cancer with special respect to uterine
cancer. Therapeutic lymphadenectomy is performed for
control of regional tumor spread; dependent on the
original site of the primary tumor, however, it has man-
datorily to be combined with complete removal of the
appropriate local compartment at risk. In the case of
cervical cancer, the removal of the local compartment
can be performed as a total mesometrial resection as
already outlined. This technique has been translated to
robotically assisted laparoscopic surgery (rTMMR) with
the support of Michael Höckel. To define this procedure
reproducibly with respect to anatomical landmarks, we
describe the technique step by step and present feasibility
data from the first 26 patients. We present this concept
of rTMMR internationally (the technical principles with-
out feasibility data were reported up to now in German
only and, therefore, are not accessible to the majority
of international oncological surgeons [14]) intending
to provoke scientific discussion within the community
of surgical oncologists. This discussion should primarily
take place with respect to the impact of robotically
assisted compartment-adapted radical hysterectomy in
cervical cancer; however, it also demonstrates the im-
pact of exact visual definition of crucial surgical steps
for future research in surgical oncology and comparison
of clinical data.Methods
Surgical technique
The first author has been trained in the surgical tech-
nique of TMMR and tLNE, attending in the Leipzig
School of Surgery in 2006. All radical hysterectomies were
consequently performed using the ontogenetically derived,
nerve-sparing technique of TMMR and tLNE, if ad-
equate. In 2010, robotically assisted laparoscopic surgery
was implemented using a da Vinci™ Surgical System
(Intuitive Surgical Inc., Sunnyvale, CA, USA). The princi-
ples of the surgical steps were systematically translated
to robotic surgery and optimized to guarantee the same
radicalness compared to open surgery but preserving
the advantages of an endoscopic approach. The different
steps were discussed with M. Höckel by video sequences.
Finally, M. Höckel participated in the surgery in Essen
and confirmed the equality of the robotic approach with
respect to his operation technique defined by open sur-
gery. The resulting rTMMR technique will be described
in detail.
Preparation of the patient: identical to laparoscopy,
Trendelenburg positioning of at least 25 to 30 degrees.
Side docking of the patient cart. Positioning of the tro-
cars: camera trocar 10 cm to 15 cm supraumbilically
(that is 25 cm above the symphysis), two lateral robotic
trocars about 5 cm to 10 cm above the upper anterior
iliac spine on both sides, that is one additional robotic
trocar on the left between the camera trocar and left lat-
eral trocar, one assistant trocar of 10 mm diameter on
the right side between the camera trocar and right lat-
eral trocar. The space in between the trocar incisions
should be at least 10 cm to ensure free adequate mobil-
ity (Figure 1).
Patients and specimens
As a first proof of feasibility, 26 patients with cervical
cancer FIGO stage IA-IIB were treated by robotic total
mesometrial resection (rTMMR) +/− robotic therapeutic
lymphadenectomy (rtLNE). All patients gave their informed
consent to the procedure. Therapeutic lymphadenec-
tomy was performed by robotic surgery in analogy to
the procedure described by M. Höckel [6,9]. The complete
clearance of the lymph node basins of the lymphatic
drainage system - including the intercalated mesometrial
nodes and the lymph basins - downstream to the
Müllerian compartment was defined to be a superior
quality parameter compared to the number of removed
lymph nodes as described previously by the authors
[15]. The lymph node basins for cervical cancer include:
paravisceral nodes (internal iliac nodes including
gluteal and rectal nodes, (pv)), external iliac nodes
(ei) first line, and common iliac nodes (ci) and presacral/
subaortic nodes (ps) on both sides, second line. Periaortic






Figure 1 Positioning of trocars for rTMMR and rtLNE in cervical cancer. rtLNE, robotic therapeutic lymphadenectomy; rTMMR, robotic total
mesometrial resection.
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in case of pelvic nodal disease, since these basins have
to be considered tertiary and quaternary with respect to
the cervix. Perioperative morbidity and early postoperative
morbidity were analyzed. In addition, we noted periopera-
tive blood loss by hemoglobin levels and frequency of
perioperative blood transfusions. The tumor-related
outcome was recorded.
Statistical analysis
Analysis of clinical and histopathological data was per-
formed using SPSS version 17.0 for Macintosh™ (SPSS,
Chicago, IL, USA). We conducted a descriptive analysis
only, considering the limited number of patients and
the explorative character of this analysis.
Technique and results
rTMMR with tLNE were performed in a steep Trendelen-
burg position, trocar positioning is depicted in Figure 1.
Prior to rTMMR, therapeutic lymphadenectomy starting
at the aortic bifurcation has been performed as specified
previously [15]. Accordingly, all regional nodes of lymph
node basins at risk are removed, except for intercalated
mesometrial nodes located predominantly in the vascular
mesometrium.
Prior to the standardized description of rTMMR, the
principles and nomenclature of M. Höckel’s method should
be commemorated. As shown in Figure 2, the Müllerian
compartment consists of the uterus, the fallopian tubes,
the vascular mesometria and the fibrofatty (ligamentous)
mesometria (mesocolpia) and the proximal vagina. The
vascular mesometria correspond to the tissue surround-
ing and accompanying the uterine vessels to the iliac
vessels and along their anastomoses to the vesical vessel
system anteriorly. The fibrofatty (ligamentous) mesometria
(mesocolpia) correspond to the sacrouterine and rectouterine/
vaginal ligaments posteriorly, which insert dorsally/laterallyalong the pubo- and ileococcygeus muscles and medially
at the mesorectum and the rectovaginal septum. Thus,
this structure forms a complex geometry of a half-cylinder
sagittally curved according to the pelvic axis. All these
structures have to be removed completely. Only the
vagina, also belonging to the Müllerian system with its
upper two-thirds, should not be removed completely for
functional reasons. Consequently, the resection at the
level of the vagina should have wide clear margins con-
firmed by histology. With respect to all other resection
borders, clear margins are achieved by removal of the
total Müllerian compartment irrespective of the dis-
tance to the resection border as long as the tumor does
not transgress the compartment.
The removal of the uterus, the fallopian tubes, the vas-
cular and ligamentous mesometria and the part of vagina
starts dorsally.
Step 1. First, the peritoneum will be incised pararectally
to the pouch of Douglas from right to left and the rectum
is mobilized medially from the vaginal wall (Figure 3).
Rectovaginal and rectouterine ligaments that form the
medial part of the ligamentous mesometrium are later-
alized until their insertion into the perirectal tissue is
reached.
Step 2. Now, the ureter is identified and prepared in
continuation with the mesureter and the adjacent inferior
hypogastric plexus and nerve. Thus, the avascular plain
between the lateral part of the ligamentous mesometrium
(that is the sacrouterine ligament) may easily be opened
and the nerve plain can be dissociated laterally from the
mesometrium (Figure 4).
Step 3. The medial and lateral part of the ligamentous
mesometrium may now be completely exposed (Figure 5)
and resected first laterally, pararectally to the pelvic
wall (the sacrouterine part, along the coccygeus and
iliococcygeus muscle and the endopelvic fascia, Figure 6)









Figure 3 Incision of the pouch of Douglas to develop the rectovaginal space and prepare the medial aspect of ligamentous mesometria
(rectovaginal ligaments).
Figure 2 The structures of the female genital tract with reference to the embryologic Müllerian compartment (green) and the
corresponding primary and secondary lymph basins (from Höckel et al., Resection of the embryologically defined uterovaginal (Müllerian)
compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol 2009, with permission from ELSEVIER).
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Figure 4 Preparation of the lateral part of ligamentous mesometria demonstrated on the right. Developing of the avascular space
between the ureter, the mesureter and the inferior hypogastric plexus laterally/ventrally and the ligamentous mesometrium medially/dorsally (the
sacrouterine ligament).
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starting on the right (resection lines, Figure 8), finaliz-
ing on the left (Figure 9).
Step 4. To detach the vesicouterine attachment, the
anterior surface of the uterus has to be exposed and put
under tension to facilitate incision of the peritoneum at
the vesicouterine fold. The peritoneum has to be incised
in the direction of the lateral part of the round ligaments
to divide these at the entrance to the inguinal channel.
The loose connective tissue is dissected until the uretersFigure 5 Overview following the preparation of the ligamentous mes
(rectovaginal, on the left) and the lateral aspect (sacrouterine, on theare identified entering the vesical wall (Figure 9). The
preparation is extended laterally and the border of the
vesical and Müllerian compartments is identified.
Step 5. Now, the umbilical artery is identified and
completely prepared to its origin from the internal iliac
artery. Thus, branching of the uterine artery and one or
more superior vesical arteries can be easily identified
(Figure 10).
Step 6. At this time, the vascular mesometrium can be
exposed, first, by developing the avascular space betweenometria with simultaneous demonstration of the medial
right).
Figure 6 Lateral resection line of the ligamentous mesometrium on the right starting from the ‘ridge’ pararectally, following the dorsal/lateral
rim of the inferior hypogastric plexus to the insertion along the iliococcygeal and pubococcygeal muscle and the fascia endopelvina.
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the superior vesical artery (Figure 11) second, by develop-
ing the avascular space between the posterior surface
and the plain of the ureter, mesureter and hypogastric
plexus (Figure 12). The caudal border of the vascular
mesometrium is marked by the deep uterine vein, which
should also be resected.
Step 7. The complete resection of the vascular mesome-
trium including all paracervical/mesometrial intercalated
nodes starts with the coagulation and division of the
uterine artery and superficial veins at their origin from
the iliac vessels. This step should be carried out without
separating the vessels in order to remove all perivascularFigure 7 Medial resection of the ligamentous mesometrium on the ri
junction along the descendant branch of the rectal artery to separatelymphatic tissue. The deep uterine vein is identified and
coagulated separately (Figure 13).
Step 8. Dissection of the ureteral branch of the uterine
artery (and vein) following elevation of the uterine bun-
dle to mobilize the ureter in its ‘tunnel’ (Figure 14). Co-
agulation and dissection of vesicouterine/vaginal arterial
anastomoses in the anterior part of vesicouterine ligament
to separate the Müllerian from the vesical compartment
ventrally, carefully preserving the ureteral branches of the
bladder mesentery (Figure 15).
Step 9. Dissection of the uterine nerve fibers at the
lateral posterior aspect of the cervix (Figure 16). The







Recto-vaginal part sacrouterine part
of resection line of ligamentous mesometrium
Vagina
Rectum
Figure 8 Topography demonstrating complete resection of the ligamentous mesometrium on the right keeping the mesorectum and
the inferior hypogastric plexus intact.
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ureter to preserve them.
Step 10. Dissection of the ‘ladder-like’ arranged vesico-
vaginal venous anastomoses (Figure 17), if not already
done during the separation of the ventral aspect of the
vascular mesometrium from the bladder mesentery (the
so-called ‘posterior leaf of the vesicouterine ligament’).
Step 11. Definition of the vaginal resection plane and
dissection of the paracolpium, if necessary. Opening the
vagina dorsally and the resection of the vaginal cuff
with sufficiently clear margins confirmed by frozen sec-
tion (Figure 18).Left ligam
lateral (s
Ureter Mesureter
A. and V. iliaca externa  
Left
Figure 9 Lateral resection line of the ligamentous mesometrium on tStep 12. Removal of resected tissue, bags and sponges,
and confirmation of clear margins. The vagina is closed
by running suture (Figure 19).
Finally, all tissue of the Müllerian compartment has
been removed completely, but adjacent structures such
as the ureter, mesureter, hypogastric plexus, rectal and
vesical mesentery are entirely preserved (Figure 20). Thus,
this procedure may be performed identically for all
compartment-defined cervical cancers ensuring max-
imum radicalness with respect to tumor resection with-
out increasing morbidity by extending radicalness to
neighboring structures. The adaption of surgery toentous mesome trium
acrouterine) part
Plexus hypogastricus inferior Rectum 
Cervix
he left during resection.
Figure 10 Separation of the Müllerian compartment from the bladder compartment anteriorly, preparing the ureteral entrance to
the bladder wall from medially exposing the vesicouterine arterial vessels connecting the Müllerian with the bladder compartment
(the anterior part of the vesicouterine ligament) shown on the right.
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unnecessary morbidity.
In contrast to M. Höckel, we do not readapt the nat-
ural sigma adhesions, representing the sole difference to
the original method described for open surgery. How-
ever, this may be easily implemented if desired.
Results
In total, 26 patients with the diagnosis of cervical can-
cer underwent surgery. All patients received a totalFigure 11 Preparation of the vascular mesometrium (the upper ridge
avascular plane dorsally with separation of the ureter, the mesuretermesometrial resection of the uterus. Therapeutic pelvic
and, if necessary, periaortic lymphadenectomy was added
when indicated.
Three patients had been treated by radiochemotherapy
first due to positive periaortic nodes and/or local inop-
erability. In these patients, TMMR was performed as
‘adjuvant’ treatment after completion of radiochemo-
therapy. In all other patients, surgery was the primary
treatment. The mean age of the patients was 49.5 years
(31 to 75 years). The mean body mass index (BMI) of themarked by the uterine artery) on the right dissecting the














Figure 12 Dissection of the vesical compartment (the proximal bladder mesentery) from the anterior surface of the vascular mesometrium
by separating the bordering lamella of the two compartments on the right to prepare its complete resection containing blood and
lymphatic vessels and intercalated nodes.
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preoperative comorbidity and prior intraabdominal sur-
gery was noted in 54%.
The distribution of the FIGO stages and surgical pro-
cedures can be seen in Table 1. There were 20/26 squa-
mous cell cancers (77%) and 6/26 adenocarcinomas.
Positive nodes were detected in 5/23 (22%) patients with
primary surgery, whereas one of the patients who had
primary radiochemotherapy had positive periaortic nodes





Figure 13 Identification of the deep uterine vein and dissection of va
vessels shown on the left.tumors (G3) was 5/23 (22%) and 5/23 (22%) tumors
showed lymphangioinvasion (L1).
All interventions were performed as intended without
modifications and no transition to open surgery was
necessary due to complications or technical problems.
Tumor resection was microscopically confirmed being
complete (R0) in all cases. Mean lymph node count was
32.4 for pelvic and 42.2 for pelvic and periaortic lymph-
adenectomy, respectively. Periaortic lymphadenectomy
was performed inframesenterically only in the case oflis sinistra 




scular mesometrium at the level of the origin from internal iliac
Figure 14 Elevation of the dissected vascular mesometrium and dissection of the ureteral branches of the uterine vessels to separate
the ureter from the vascular mesometrium on the left.
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not the number of nodes, but video-documented, complete
clearance of lymph node basins that was taken as cri-
terion for sufficient therapeutic lymphadenectomy as
outlined in [13].
There were no intraoperative complications, in total
postoperative complications occurred in six patients
(23%). Two had minor local wound infection, two infected





Figure 15 The vascular mesometrium can now be flipped dorsally wi
can be exposed from laterally on the left (the vesicouterine ligament
dissected at their free part close to their junction to the bladder vessels.laparoscopic revision for bleeding and one patient had a
vaginal cuff dehiscence.
With respect to blood loss, hemoglobin levels were
determined pre- and postoperatively (on the first day).
Mean decrease of hemoglobin concentration was deter-
mined to be 2.1 g/dl in TMMR (0.5 to 3 g/dl), 3.3 g/dl
in TMMR and pelvic lymphadenectomy (1.1 to 4.9 g/dl)
and 3.3 g/dl in TMMR and pelvic/periaortic lymphade-
nectomy (2.4 to 4.6 g/dl). Blood transfusion was appliedArterial vesicouterine anastomoses






thout elevating the ureter and the vesicouterine vascular junction
). The connecting vessels and the accompanying connective tissue are
Cervicovaginal
junction














Figure 16 To separate the inferior hypogastric plexus, the mesureter and the ureter en bloc from the Müllerian compartment, the
uterus-supplying nerve fibers have to be dissected at their branching laterodorsally of the cervix as shown on the left.
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levels of 7.8, 8.3, 8.6 and 10.3 g/dl. Mean follow-up of the
patients was 18 months (range 2 to 27 months). One
patient who had received primary radiochemotherapy
was lost to follow-up. There was one distant recurrence
(1/25 corresponding to 4%). One intercurrent death
occurred at 18 months postoperatively without evidence
of tumor recurrence or association to cancer therapy.Ureter sinister 
A. vesicalis sup
Plexus hypogastricus inferior  
A. umbilicalis sinistra  
Figure 17 Finally, the vesicouterine/vesicovaginal venous anastomose
vesicouterine ligament have to be dissected to complete the dissectiNo patient has died of tumor or sequelae of the tumor-
associated therapy during the observation period.
The patient with recurrence presented with stage pT2b,
pN1, G2 and had a rupture of the anterior cervical fascia
during surgery with exposure of the tumor to the surgical
field. She refused radiation therapy and developed trocar
site recurrence after 9 months, treated by radiation
therapy and surgical excision, respectively. There waserior  
Vesicouterine venous anastomoses 
(lig. vesicouterinum) posterior part 
Bladder  wall 
Uterus 
s dorsally to the ureter representing the posterior part of






Plexus hypogastricus inferior 
Ureter
left
Figure 18 Following the definition of the vaginal resection line and adequate preparation of the mesocolpium, the incision of the
vaginal wall starts dorsally on the left and will be continued dorsally to the right following the right side wall to the anterior wall
ending up again on the left. Tumor exposition has to be avoided during removal of the specimen.
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months after diagnosis of recurrence, she was doing
well without evidence of disease.
Discussion
We were able to show that the principle of compartment-
based surgery performed as total mesometrial resection
(TMMR) combined with therapeutic lymphadenectomy
(tLNE) as described by M. Höckel [9,10] can systemat-
ically be translated to minimally invasive, robotically
assisted procedures (rTMMR and rtLNE). Robotic sur-
gery enables us to develop and dissect structures withFigure 19 Closure of the vagina by running suture. A tight closure of thehigh ‘optical’ accuracy, thus allowing us to prepare and
remove compartment-associated tissue completely without
injuring adjacent structures by respecting the filmy septa
at the compartment borders; thus, excellent visual docu-
mentation by HD video recording is dramatically facilitated.
The method appears to be feasible and safe. It has to
be considered that the presented data were collected
consecutively during the first attempts in this surgical
procedure. However, the mean follow-up time of 18 months
is limited and the number of patients (with respect to
the fact that six patients at FIGO stage IA and three
patients who had prior radiotherapy were included) islateral angles can avoid the development of vaginal vault dehiscense.
Figure 20 Pelvic topography following TMMR demonstrating complete resection of the Müllerian compartment including the vascular
and ligamentous mesometria except for the retained part of the vagina. It is clearly visible that the plane of the ureter, mesureter and
inferior hypogastric nerve plexus are completely intact on both sides. TMMR, total mesometrial resection.
Kimmig et al. World Journal of Surgical Oncology 2013, 11:211 Page 13 of 15
http://www.wjso.com/content/11/1/211admittedly small, it should be noticed, nevertheless that
there has been no locoregional tumor recurrence dur-
ing this observation period. Thus, it may be assumed
that laparoscopic, robotically assisted TMMR and tLNE
(rTMMR and rtLNE) may be safe with respect to local
tumor control. This would be in accordance with the
impression that due to the excellent 3D vision, along
with the magnification of the surgical field and the high
precision and control of movements, the accuracy of
this technique may be considered at least equivalent to
open surgery. Therefore it may be assumed that a com-
parable radicalness may be achieved.
As a consequence, further development of minim-
ally invasive surgical techniques for treatment for cer-
vical cancer confined to the Müllerian compartment
should focus on evaluation of rTMMR and rtLNE. First,
compartment-based surgery appears to exert excellent
locoregional control in cervical cancer combined with a
low complication rate as shown for open surgery [10,13].
Second, the translation to a minimally invasive methodTable 1 Correlation of tumor stage, preoperative treatment, l
surgical procedure
Patients FIGO Stage
radiIA IB II A/B
TMMR only 6 3 0 0
TMMR and pelvic LNE 15 4 10 1
TMMR, pelvic and pa LNE 5 0 4 1*
Total 26 7 14 2
*And partial colpectomy. TMMR total mesometrial resection, pa LNE periaortic lympby robotic assistance adds the advantages of minimally
invasive surgery regarding blood loss, mobilization, length
of hospitalization and short-term complications as it has
previously been shown for robotic surgery [16,17]. With
respect to the port-site recurrence in our report, we stress
that exposure of the tumor to the surgical field must
strictly be avoided. Although port-site metastases are a
well-known phenomenon, they seem to be a rare event
[18,19]. In robotic surgery, it is reported that the rate of
port-site metastases is low and similar to conventional
laparoscopy [20,21]. Nevertheless, we recommend ensur-
ing that no direct contact of the tumor with the operative
field takes place. In this regard, we consider the closure
of the cervical channel or the vagina prior to the open-
ing of the vagina abdominally an important procedure
in uterine cancers.
Conclusions
In conclusion, we suggest that the minimally invasive
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and may be beneficial for patients with cervical cancer
confined to the Müllerian compartment. In order to
evaluate whether the excellent monocentric data with
outstanding locoregional tumor control and low mor-
bidity of M. Höckel in cervical cancer [6,9,10] holds
true in a multicentric setting, an observational study has
been initiated. Starting recruitment in 2013, results of
TMMR and tLNE with respect to morbidity and survival
will be analyzed. Participation will be independent of
surgical access - open or laparoscopic or laparoscopic
robotically assisted - but requires verifiable standardization
with an accordant training of TMMR, tLNE and patho-
logical workup. For robotically assisted total mesometrial
resection (rTMMR) the technique described in this publi-
cation will be the reference basis. Interested experienced
surgeons who are willing to fulfill the requirements are
invited by the first author to apply for participation.
In future, from our point of view, this kind of prepar-
ation and auditing of surgical studies could contribute
to a better comparability between different sites and
surgeons, which is not only mandatory in scientific studies,
but may also beneficial in education and clinical practice.
The clear definition of a surgical procedure, supported by
educational illustrations and videos may serve as a pioneer
of a new generation of surgical studies and - not least -
surgical education.
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